Previous studies have reported the GH-IGF-I axis plays an important role in multiple brain functions and might be targeted as a promising therapy for neurodegenerative diseases such as Amyotrophic lateral sclerosis, Alzheimer's disease, Parkinson's disease, and dementia (33–36). This evidence concerns the gene IGF1 and Parkinson disease.